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Background: Following acute myocardial infarction (AMI), microvascular obstruction (MO) and intramyocardial
hemorrhage (IMH) adversely affect left ventricular remodeling and prognosis independently of infarct size. Whether
this is due to infarct zone remodeling, changes in remote myocardium or other factors is unknown. We
investigated the role of MO and IMH in recovery of contractility in infarct and remote myocardium.
Methods: Thirty-nine patients underwent cardiovascular magnetic resonance (CMR) with T2-weighted and T2*
imaging, late gadolinium enhancement (LGE) and myocardial tagging at 2, 7, 30 and 90 days following primary
percutaneous coronary intervention for AMI. Circumferential strain in infarct and remote zones was stratified by
presence of MO and IMH.
Results: Overall, infarct zone strain recovered with time (p < 0.001). In the presence of MO with IMH and without
IMH, epicardial strain recovered (p = 0.03, p < 0.01 respectively), but mid-myocardial or endocardial strain did not
(mid-myocardium: p = 0.05, p = 0.12; endocardium: p = 0.27, p = 0.05, respectively). By day 90, infarcts with MO had
more attenuated strain in all myocardial layers compared to infarcts without MO (p < 0.01); those with IMH were
attenuated further (p < 0.01). Remote myocardial strain was similar across groups at all time-points (p > 0.2). Infarct
transmural extent did not correlate with strain (p > 0.05 at each time point). In multivariable logistic regression, MO and IMH
were the only significant independent predictors of attenuated 90-day infarct zone strain (p = 0.004, p = 0.011, respectively).
Conclusions: Strain improves within the infarct zone overall following reperfusion with or without MO or IMH.
Mid-myocardial and endocardial infarct contractility is diminished in the presence of MO, and further in the
presence of IMH. MO and IMH are greater independent predictors of infarct zone contractile recovery than
infarct volume or transmural extent.
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Following reperfused acute myocardial infarction (AMI),
the left ventricle (LV) undergoes structural alterations
both within and outside of the area of infarction, re-
ferred to as LV remodeling. The pathophysiology of this
process is complex, with multiple ultrastructural, meta-
bolic and neurally mediated processes occurring in in-
farcted and remote myocardium [1]. In up to 30% of
patients, coronary reperfusion is associated with micro-
vascular obstruction (MO) [2], seen angiographically as
‘no-reflow’ [3]. MO has been associated with adverse
prognosis, adverse LV remodeling and diminished recov-
ery of LV function, independently of infarct size [4,5]. Re-
perfusion may also lead to intramyocardial hemorrhage
(IMH) in the infarct core [6] via extravasation of blood
through damaged endothelium [7]. Like MO, IMH is asso-
ciated with adverse LV remodeling and adverse prognosis,
independently of infarct size [8]. The mechanisms by
which MO and IMH affect LV remodeling are poorly
understood. Specifically, it is not known how they affect
local remodeling and recovery in the infarct zone com-
pared with remote myocardium.
Cardiovascular magnetic resonance (CMR) can non-
invasively evaluate myocardial infarction, MO and IMH.
Enhanced myocardium on late gadolinium enhancement
(LGE) imaging correlates with infarction histologically [9],
whilst a hypoenhanced infarct core on LGE corresponds
to MO [10]. IMH has been assessed by T2-weighted
(T2w) and T2* CMR [8,11-13]. In chronic infarction, in-
creasing transmural extent of infarction with LGE imaging
correlates with impaired recovery of contractile function
after revascularization [9]. However, in AMI, LGE can
overestimate infarct size [14]. Within enhanced myocar-
dium on LGE, contractile activity has been demonstrated
both by measures of strain at rest [15], and as contractile
reserve with dobutamine [16]. Contractile function can
also be measured by CMR, using myocardial tissue tag-
ging, allowing a direct comparison of contractility and in-
fract characteristics from CMR data. We sought to
investigate how MO and IMH affect contractile function
as measured by tissue tagging CMR in infarcted and re-
mote myocardium acutely and late following AMI.
Methods
This prospective study was undertaken in a single ter-
tiary center. Other analyses from this study have been
reported previously [17]. The study protocol was ap-
proved by the institutional research ethics committee
and complied with the Declaration of Helsinki; all pa-
tients gave written informed consent. Patients with first
AMI, revascularized by primary percutaneous coronary
intervention (PCI) within 12 hours of onset of pain were
included [8]. Myocardial infarction was defined by symp-
toms consistent with acute myocardial ischemia, withelectrocardiographic ST-segment elevation or new onset left
bundle branch block associated with a rise and/or fall in car-
diac enzyme concentration. Exclusion criteria were previous
MI or coronary revascularization, estimated glomerular
filtration rate <30 ml/min/1.73 m2, cardiomyopathy, or
contraindications to CMR. Patients with maximal cir-
cumferential extent of myocardial scar <4 mm, without
scar on adjacent slices were deemed too small for ac-
curate tagging analysis and excluded from the analysis.
Clinical management (including use of aspiration cath-
eters and glycoprotein IIb/IIIa receptor inhibitors) was
at the discretion of the responsible physician, with the
intention to reflect contemporary practice and guide-
lines. CMR results were not revealed to the clinical
team. All patients were considered for beta-blockade,
angiotensin converting enzyme inhibitors, statins, dual
antiplatelet therapy, and cardiac rehabilitation.
Image acquisition
All patients had CMR on a 1.5 T system (Intera CV,
Philips Healthcare, Best, The Netherlands) within 3 days
of their index presentation and at 7–10, 30 and 90 days
post-AMI. The same CMR protocol was used for each of
the visits. A stack of images covering the whole LV, with
the same slice geometry, position and slice thickness
were used for all sequences. Cine imaging used a steady
state free precession (SSFP) pulse sequence (echo time
(TE) 1.4 ms; repetition time (TR) 2.8 ms; flip angle 55°,
spatial resolution 2 × 2 × 10 mm, ≥18 phases per cardiac
cycle), covering the whole heart in parallel short axis
slices. To minimize differing volume effects between
image types, 10 mm slice thickness was used for all se-
quences. Tagged CMR used a complementary spatial
modulation of magnetization (CSPAMM) pulse se-
quence (spatial resolution 1.67 × 1.67 × 10 mm, no gap,
tag separation 8 mm, ≥18 phases, typical TR/TE 30/
6 ms, flip angle 20°). T2w CMR used a dark-blood T2w
short tau inversion-recovery fast spin echo sequence (TE
100 ms, TR 2x R-R interval, flip angle 90°, spatial reso-
lution 1.43 × 1.43 × 10 mm). T2* images were obtained
with a dual echo T2* gradient echo sequence (TE 4.6/
9.2 ms, TR 12.3 ms, flip angle 30°, spatial resolution 1.43 ×
1.43 × 10 mm). A dose of 0.2 mmol/kg of gadolinium-
DTPA (dimegluminegadopentetate; Magnevist, Bayer, Berlin,
Germany) was then administered using a power injector
(Spectris, Solaris, PA). A short-axis LGE stack was acquired
after 10 minutes (inversion recovery-prepared T1 weighted
gradient echo, inversion time according to a Look-Locker
scout, TR/TE 4.9/1.9 ms, flip angle 15°, spatial resolution
1.35 × 1.35 × 10 mm). For follow-up, care was taken to en-
sure similar slice positioning, by aligning the proximal
border of the most basal slice of the short axis stack to the
mitral valve annulus in end-diastole and comparing slice
position to the index scan.
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Images were analyzed offline using commercial software
(MASS 7.2; Medis, Leiden, The Netherlands and Tagtrack
1.8; Biomedical engineering, ETH Zurich, Switzerland).
Infarct location was determined by CMR, according to
standard guidelines [18]. In addition to the alignment of
slices during image acquisition, we verified accurate align-
ment of serial scans by comparing features such as the
presence and shape of papillary muscles. Left ventricular
volumes and wall thicknesses were analyzed from SSFP
cine-imaging. Infarcts and MO were measured from LGE
images. Infarct was defined as an area of LGE ≥2 standard
deviations (SD) above remote myocardium, and infarct
volume estimation included any hypointense core. This
cut-off was chosen for consistency with analysis of T2w
images. MO was defined visually as the hypointense core
within the infarcted zone and planimetered manually.
Volumes of infarct and MO were calculated from
planimetered areas across the whole LV stack by the
modified Simpson’s method. The presence and extent
of myocardial hemorrhage was assessed by combined
analysis of T2w and T2* sequences [8]. On T2w im-
ages, areas with mean signal intensity more than 2 SD
below the periphery of the area at risk (AAR) were
considered to be hemorrhage [11,13]. On the T2* im-
ages, the presence of a dark core within the infarctedFigure 1 Patient with MO and IMH (a-d). LGE image demonstrates anter
hypoenhanced core corresponds to MO (a, arrowed). T2w (b) and T2* (c) im
Strain measurements in epicardial, mid-myocardial and endocardial tracks a
arrangement of images for infarction with MO but no IMH is shown (e-h).
(arrowed). A patient without MO is shown (i-l).area by visual inspection of the images was used as
confirmation of myocardial hemorrhage. Only when
T2w and T2* images showed concordant findings was
an area considered to represent hemorrhage.
For CSPAMM analysis, endocardial and epicardial bor-
ders were drawn by a semi-automated process, and a
midline calculated automatically. To minimize partial
volume effects, strain was measured in the single short
axis slice which demonstrated maximal infarction on
LGE imaging. One short axis slice per patient at each
time point was analyzed for strain. In all cases, this slice
was in the same position along the long axis for each of
the time points in a given patient, and every slice had
LGE on the adjacent slices. Circumferential Lagrangian
strain was measured at endocardial, mid-myocardial and
epicardial layers through the infarct and remote zones
(Figure 1). Remote strain measurement was taken in a
30 degree arc of myocardium diametrically opposite to
the infarct zone. No patient had LGE in remote myocar-
dium. To minimize the effects of passive post-systolic
shortening [19], strain was measured at end systole,
taken as the phase at the time of end-systole on the cor-
responding SSFP cine slice.
Transmural extent of infarction was graded into quar-
tiles at each time point from anonymized LGE images at
the same position as the selected CSPAMM slice byior and septal enhancement, corresponding to scar. The central
aging show central hypoenhancement (arrowed), indicative of IMH.
re measured (d) for infarcted (1) and remote (2) zones. A similar
Note absence of central hypoenhancement in T2w and T2* sequences
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results of other sequences.Statistical analysis
Statistical analysis was performed using IBM SPSS® Sta-
tistics 19.0. Continuous variables were expressed as
means ± SD. Correlation between T2w and strain data
were derived using Spearman’s rank test; differences in
strain and size measurements over time were evaluated
using repeated measures analysis of variance (ANOVA);
post-hoc testing was performed with the Bonferroni cor-
rection. Differences in transmurality quartiles over time
were evaluated with the Friedman test. Normality for
strain data was established using the Kolmogorov-
Smirnov test. Differences in infarct pathophysiology at a
single time point were evaluated using one-way
ANOVA; post-hoc testing was performed with Tukey’s
test. Univariable analyses were performed to identify
predictors of reduced strain at 90 days. Variables with
a probability value <0.1 in the univariable analysis were
included in a multivariable analysis, which was based
on a logistic regression model with a repeated mea-
sures variable (to adjust for non-independence of
strain data). All statistical tests were 2-tailed; P values
<0.05 were considered significant. Error bars for mean
values denote standard error.Table 1 Patient characteristics
No MO or IMH (n = 17)
Age, years 58 ± 10
Male 16 (94%)
Current smoker 9 (53%)
Hypertension 7 (41%)
Hypercholesterolemia 11 (65%)
Family history of premature heart disease 6 (35%)
Diabetes mellitus 0 (0%)





GP†IIb/ÍIIa inhibitor used 3 (18%)
TIMI flow pre-PCI≥ 2 4 (24%)
TIMI flow post PCI
Grade 2 1 (6%)
Grade 3 16 (94%)
Peak CK‡ (U/l) 1234 ± 976
Data as mean ± SD or n (%). *IQR interquartile range, †GP glycoprotein, ‡CK creatineResults
Demographics
50 patients met the inclusion criteria. Two patients were
excluded due to claustrophobia, 2 refused follow-up and
1 died before completing follow-up. In 6 other patients
the tagging software failed to accurately track the tagged
images due to artifact. Therefore 39 patients completed
baseline and follow up scans and were included in the
statistical analysis. Of these, 10 patients had tagging and
T2w imaging at either day 2 or day 7, with 29 having
these images at both these time points. All 39 had im-
aging at day 30 and day 90.Infarct characteristics
Patient data were divided into three groups for analysis;
patients without MO or IMH, patients with MO but no
IMH, and patients with both MO and IMH. No patient
had IMH without MO. Patient characteristics were simi-
lar between the three groups (Table 1). Infarct character-
istics are shown in Table 2.
Patients without MO or IMH had similar infarct size to
patients with MO, but those with IMH had significantly
larger infarcts than patients without IMH both at baseline
(mean infarct volume 41 ± 20 ml vs. 21 ± 16 ml, p = 0.02)
and 90 days (mean infarct volume 21 ± 16 ml vs. 14 ±
10 ml, p < 0.01). Infarct size decreased significantlyMO only (n = 8) MO and IMH (n = 14) p value
55 ± 9 59 ± 8 0.70
8 (100%) 10 (71%) 0.12
4 (50%) 7 (50%) 1.00
3 (38%) 1 (7%) 0.08
3 (38%) 8 (57%) 0.50
3 (38%) 6 (43%) 0.91
1 (13%) 1 (7%) 0.31




3 (38%) 4 (29%) 0.64
0 (0%) 1 (7%) 0.25
1 (11%) 0 (0%) 0.69
8 (89%) 14 (100%)
1711 ± 1442 2640 ± 1997 0.051
kinase.
Table 2 Infarct characteristics
Days post AMI No MO or IMH MO only MO and IMH p value between groups
2 Ejection fraction,% 45 ± 10* 42 ± 5* 38 ± 9* 0.10
LV EDVi†, ml/m2 85 ± 14 96 ± 15* 93 ± 22 0.27
LV ESVi‡, ml/m2 47 ± 14* 56 ± 14* 58 ± 20 0.16
LV end-diastolic wall thickness, infarct zone, mm 8 ± 2* 9 ± 2 8 ± 2 0.72
LV end-diastolic wall thickness, remote zone, mm 7 ± 1 8 ± 1 7 ± 1 0.78
LV mass, g/m2 58 ± 15* 59 ± 11* 57 ± 19* 0.92
LGE infarct volume, ml 21 ± 16* 32 ± 17 41 ± 20* 0.02
Median LGE infarct transmural extent 75-100% 75-100% 75-100%* 0.10
LGE MO volume, ml - 3 ± 3* 4 ± 4* 0.41
90 Ejection fraction,% 51 ± 9* 50 ± 5* 42 ± 8* <0.01
LV EDVi, ml/m2 85 ± 19 90 ± 14* 100 ± 27 0.17
LV ESVi, ml/m2 42 ± 17* 45 ± 11* 59 ± 23 0.04
LV end-diastolic wall thickness, infarct zone, mm 7 ± 1* 7 ± 1 6 ± 1 0.13
LV end-diastolic wall thickness, remote zone, mm 7 ± 2 7 ±1 7 ± 1 0.72
LV mass, g/m2 55 ± 15* 56 ± 11* 52 ± 18* 0.82
LGE infarct volume, ml 14 ± 10* 16 ± 7 29 ± 16* <0.01
Median LGE infarct transmural extent 75-100% 75-100% 50-75%* 0.73
Data as mean ± SD or n (%) unless indicated. *Characteristics that are significantly different between day 2 and day 90 are indicated. †LV EDVi Left ventricular end
diastolic volume, indexed to body surface area, ‡LVESVi Left ventricular end systolic volume, indexed to body surface area.
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0.01; MO with no IMH group, F = 9.8, p < 0.01; MO and
IMH group, F = 7.2, p = 0.01) (Table 2 and Figure 2).
There was also a significant decrease in infarct transmural
extent over time in the patients with MO and IMH (p <
0.01), but not in patients with MO and no IMH (p = 0.1)
or without MO or IMH (p = 0.6) (Table 3). There was noFigure 2 Mean infarct zone size at 4 time points post AMI,
stratified by presence of MO and IMH.significant difference in infarct transmural extent between
the groups at any time point (p > 0.05 at each time point).
Effects of MO, IMH, infarct size and transmural extent on
myocardial strain
Within the infarct zone, examining strain across all layers
showed overall recovery with time (F = 44, P < 0.001). For
individual layers, endocardial, mid-myocardial and epicar-
dial strain recovered over the 4 time points (p ≤ 0.01 for
each) for patients without MO or IMH. For patients with
MO, regardless of the presence of IMH, there was no sig-
nificant recovery of endocardial (F = 3.1, p = 0.05; F = 1.4,
p = 0.3 in the absence and presence of IMH, respectively)
or mid-myocardial strain (F = 2.1, p = 0.1; F = 2.9, p = 0.05
respectively), but epicardial strain recovered significantly
(F = 7.7, p < 0.01; F = 3.3, p = 0.03 respectively; Figure 3).
Analysis of individual time points showed differences
between infarcts with MO and IMH evolving over time.
At day 2, there was no significant difference in infarct
strain in endocardial, mid-myocardium or epicardial
zones according to the presence of MO or IMH (F =
0.27, p = 0.8; F = 0.27, p = 0.8; F = 1.9, p = 0.2 for endocar-
dial, mid-myocardial and epicardial strain, respectively).
By day 7, there was significant difference in endocardial
and mid-myocardial strain between the groups, but not
epicardial strain (F = 6.9, p = 0.03; F = 4.3, p = 0.02; F = 1.9,
p = 0.2 respectively). At day 30 and day 90, there were
Table 3 Summary of changes in infarct characteristics
between 2 and 90 days








Transmural extent of infarction
Magnitude of infarct endocardial
strain
Magnitude of infarct mid myocardial
strain
Magnitude of infarct epicardial
strain
Magnitude of remote endocardial
strain
Magnitude of remote mid
myocardial strain
Magnitude of remote epicardial
strain
Arrows indicate direction of change. Horizontal arrow denotes no
significant change.
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epicardial strain according to the presence of MO or IMH
(day 30: F = 3.7, p = 0.03; F = 4.5, p = 0.02; F = 5.5, p < 0.01;
day 90: F = 7.9, p < 0.01; F = 11, p < 0.01. F = 10, p < 0.01
respectively).
Remote myocardial strain was similar over time, and
similar at each time point (p ≥ 0.2 for all) regardless of
infarct characteristics (Figure 3).
At each time point, infarct zone endocardial strain was not
associated with infarct transmural extent (F = 1.1, p = 0.3;
F = 0.3, p = 0.8, F = 1.1, p = 0.3; F = 2.3, p = 0.1 for days 2, 7,
30 and 90 respectively). Endocardial strain was chosen as it
was consistently within the infarct zone.
Univariable linear regression analysis (examining the
variables in Table 4) showed that presence of MO, pres-
ence of hemorrhage and total infarct volume, but not in-
farct transmurality were significantly associated with
decreased strain in the infarct zone at 90 days. Of these,
the presence of MO and/or IMH, but not infarct vol-
ume, were significantly associated with strain on multi-
variable logistic regression analysis (Table 4).Discussion
This study has found that contractile function as mea-
sured with CMR tissue tagging improves within the
overall infarct territory following reperfused AMI with
or without the presence of MO or IMH. However, this
recovery was diminished in the presence of MO and fur-
ther in the presence of IMH. Remote myocardial con-
tractility did not change over time or with MO or IMH.
The presence of MO and/or IMH was a stronger inde-
pendent predictor of infarct zone contractile recovery
than transmural extent of infarction or overall infarct
volume.
There are limited existing data on how MO or IMH
affect infarct zone contractile recovery. In canines, the ex-
tent of MO early post MI relates to reduced deformation
and dysfunction of non-infarcted adjacent myocardium
[20]. In humans, the relationship between infarction, MO
and regional function has conflicting evidence. Rogers
et al. [15], showed that enhanced myocardium on LGE re-
covered function with time, but hypoenhanced myocar-
dium did not. Gerber et al. [21], found no significant
difference in strain between hypoenhanced and enhanced
segments 7 months following AMI. We have shown
previously that IMH on T2 and T2* imaging post-AMI
was the strongest predictor of adverse LV remodeling
globally [8], and that strain recovers significantly
within enhanced myocardium, even when accounting
for scar zone remodeling [17].
In this study, patients with IMH had significantly lar-
ger infarcts than those without, as previously observed
[8,22]. However, even when accounting for infarct size,
patients with IMH had poorer infarct zone contractile
function from day 7 onwards. The mechanisms by which
MO and IMH confer reduced LV contractile function
and adverse remodeling remain unclear [5,23], and are
not simply explained by infarct expansion. Notably, we
found no significant changes in remote strain, suggesting
that MO and IMH affect contractility by processes in or
around the infarct. Our findings of MO and IMH as the
strongest independent predictors of attenuated infarct
zone strain support this notion.
One possible interpretation of these findings is that
circumferential motion is transmitted from a viable epi-
cardial rim to the endocardium and that myocardial tag-
ging by CMR detects this passive motion rather than
active contraction. Epicardial strain recovery was con-
sistently observed in all three groups and would support
this interpretation. However, three points do not readily
concord with this interpretation: 1) the transmural ex-
tent of infarction was similar across the three groups,
and so one would expect that the magnitude of circum-
ferential compression should be similar, 2) infarct endo-
cardial strain did not show an association with infarct
transmural extent and 3) patients with fully transmural
Figure 3 Endocardial, mid-myocardial and epicardial circumferential strain at 4 time points post AMI. Infarct zone (top row) and
remote zone (bottom row) are shown.
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core of the infarct zone [17].
An alternative interpretation of our findings is that re-
sidual viable myocardium remains within the reperfused
infarct zone and that the surviving myocytes areTable 4 Predictors of decreased infarct zone strain in
univariable and standard multivariable regression
analysis
Univariable Multivariable
Variable p value p value
Age 0.40 …
Sex 0.84 …
Current smoker 0.04 …
Hypertension 0.13 …
Hypercholesterolemia 0.75 …
Family history 0.17 …
Diabetes 0.79 …
Onset to balloon time 0.18 …
Anterior AMI 0.34 …
TIMI flow grade before PCI > 0 0.69 …
TIMI flow grade after PCI < 3 0.46 …
Transmural extent of infarction >50% 0.12 …
Transmural extent of infarction 100% 0.58 …
Infarct volume (at 90 days) 0.001 0.07
Presence of MO only <0.0001 0.03
Presence of MO + IMH <0.0001 0.005responsible for the evolving contractility over time in the
infarct zone. The current literature on this issue is in-
consistent. Most of the evidence suggests that enhanced
zones on LGE imaging are entirely non-viable (reviewed
in [24]). However, it is also known that enhancement on
LGE CMR can overestimate infarct size acutely, and that
the viable, edematous borderzone can show enhance-
ment [25]. Histologically, preserved islands of viable
myocytes have been shown to exist within the infarct
zone [26]. In one study the mean myocyte fraction from
sections of scar tissue defined by LGE imaging was as
high as 62% [27].
What is less controversial is that the extent of damage
within the infarct zone varies. Ultrastructural damage is
more pronounced in areas of no-reflow [3,28] and IMH
is associated with diminished healing within the infarct
core, and altered inflammatory response [6]. It is pos-
sible therefore that any differences in contractile func-
tion and functional recovery between these pathologies
reflect the variation in the proportion of residual viable
myocytes following reperfusion that may not be appar-
ent on qualitative LGE imaging. Alternatively, these
structural differences may lead to differential transmis-
sion of epicardial contraction into the infarct zone de-
pending on the presence of MO or IMH.
Patients without MO or IMH showed recovery of strain
in the endocardial, mid-myocardial and epicardial infarct
borders, but in patients with MO (with or without IMH),
there was no significant recovery in endocardial and mid-
myocardial areas. Furthermore, when examining the
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mid-myocardial contractile function was significantly dif-
ferent at day 7 whilst this was not apparent in the epicar-
dial border until day 30. This accords with the wavefront
theory of infarction, and that MO and IMH principally de-
velop in the endocardium and mid-myocardium, with
relative sparing of epicardial ischemia and infarction prior
to reperfusion.
Hypoenhancement on LGE produces a conservative
estimate of the extent of MO [29] compared with early
gadolinium enhancement (at 2 min following contrast
injection). We chose to define MO by LGE as it is con-
sidered to be of higher prognostic value [30]. In our
study, findings on early and late gadolinium enhance-
ment were similar and only one of the 16 patients with
no MO on LGE showed MO on early enhancement im-
aging. The results and significant findings of the study
were not changed by analyzing this patient in the MO
group.
Limitations
This study has limitations. The number of patients is
relatively small, though sufficient to generate significant
results and in keeping with other CMR studies in this
demographic, where serial imaging including early post
AMI is challenging. Five patients did not have strain and
T2w imaging at baseline. It is possible that any MO/
IMH may have resolved by day 7, although of 22 pa-
tients with MO at day 2, all but one had MO at day 7.
We used a dual-echo T2* method in this study. Multi-
echo techniques permit more reliable quantitative esti-
mates of T2* but were not available to us at the time of
this study. For this reason, we only performed a qualita-
tive assessment of IMH size from T2* images. A variety
of cut-offs to define LGE enhanced myocardium have
been proposed in the literature; we chose 2SD to ensure
consistency with T2 image analysis. Using concurrent
LGE images for tagging at each time point may be af-
fected by geometric changes in the LV or infarct zone
for follow up scans, and a potential change in the pos-
ition of myocardium that is sampled. Resolving three cir-
cumferential layers in remodeled infarcted myocardium
may have been limited by the resolution of CMR, though
the harmonic phase analysis software is able to produce
a displacement map between tagging intersections to <1
mm [31], and the infarct zone did not thin in the vast
majority of patients with timely reperfusion. End systolic
strain may not account for infarct zone dyssynchrony,
though this was not observed visually in any patient.
Conclusions
The infarct zone following reperfused AMI demonstrates
contractile recovery over time as measured by tissue tag-
ging CMR. The presence of hypoenhancement on LGE,suggestive of MO, is associated with reduced functional
recovery over time, affecting in particular endocardial and
mid-myocardial functional recovery. Hypoenhancement
on T2w and T2* imaging, suggestive of IMH, is associated
with further reduction in infarct zone functional recovery.
Both MO and IMH are independent predictors of im-
paired contractile recovery in the infarct zone, but neither
independently affects remote myocardial contractility.
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